Skip Navigation

Cardiovascular Research 2004 64(1):105-114; doi:10.1016/j.cardiores.2004.06.001
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Inserte, J.
Right arrow Articles by Soler-Soler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inserte, J.
Right arrow Articles by Soler-Soler, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism*

Javier Inserte, David Garcia-Dorado*, Marisol Ruiz-Meana, Luis Agulló, Pilar Pina and Jordi Soler-Soler

Servicio de Cardiologia, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain

* Corresponding author. Tel.: +34-93-489-4038; fax: +34-93-489-4032. E-mail address: dgdorado{at}vhebron.net

Objectives: It has been shown that sarcolemmal rupture can occur during reenergization in cardiomyocytes in which previous ischemia has induced sarcolemmal fragility by calpain-dependent hydrolysis of structural proteins. We tested the hypothesis that attenuated calpain activation contributes to the protection against reperfusion-induced cell death afforded by ischemic preconditioning (IPC), and investigated the involvement of protein kinase A (PKA) in this effect. Methods: Calpain activity and degradation of different structural proteins were studied along with the extent of necrosis in isolated rat hearts submitted to 60 min of ischemia and 30 min of reperfusion with or without previous IPC (two cycles of 5 min ischemia–5 min reperfusion), and the ability of different treatments to mimic or blunt the effects of IPC were analyzed. Results: IPC accelerated ATP depletion and rigor onset during ischemia but reduced LDH release during reperfusion by 69% (P<0.001). At the end off reperfusion, calpain activity was reduced by 66% (P<0.001) in IPC, and calpain-dependent degradation of sarcolemmal proteins was attenuated. Addition of the calpain inhibitor MDL-28170 mimicked the effects of IPC on protein degradation and reduced LDH release by 48% (P<0.001). The effects of IPC on calpain, {alpha}-fodrin, and LDH release were blunted by the application of the PKA inhibitor H89 or alprenolol during IPC, while transient stimulation of PKA with CPT-cAMP or isoproterenol before ischemia attenuated calpain activation, {alpha}-fodrin degradation, and markedly reduced LDH release (P<0.001). In hearts exposed to Na+-free perfusion, IPC attenuated calpain activation by 67% (P<0.001) and reduced by 56% (P<0.001) LDH release associated to massive edema occurring during Na+ readmission without modifying its magnitude. Conclusion: These results are consistent with PKA-dependent attenuation of calpain-mediated degradation of structural proteins being an end-effector mechanism of the protection afforded by IPC.

KEYWORDS Preconditioning; Ischemia; Reperfusion injury; Protein kinase A; Calpain


* Karin R. Sipido, University of Leuven, Belgium, served as Guest Editor for this article.

Time for primary review 43 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. C. Blunt, A. T. Creek, D. C. Henderson, and P. A. Hofmann
H2O2 activation of HSP25/27 protects desmin from calpain proteolysis in rat ventricular myocytes
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1518 - H1525.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. Tanaka-Esposito, Q. Chen, S. Moghaddas, and E. J. Lesnefsky
Ischemic preconditioning does not protect via blockade of electron transport
J Appl Physiol, August 1, 2007; 103(2): 623 - 628.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. D. Arrington, T. R. Van Vleet, and R. G. Schnellmann
Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction
Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1159 - C1171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. N. Peart and G. J. Gross
Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1746 - H1753.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Ruiz-Meana, D. Garcia-Dorado, E. Miro-Casas, A. Abellan, and J. Soler-Soler
Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion
Cardiovasc Res, September 1, 2006; 71(4): 715 - 724.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Rodriguez-Sinovas, K. Boengler, A. Cabestrero, P. Gres, M. Morente, M. Ruiz-Meana, I. Konietzka, E. Miro, A. Totzeck, G. Heusch, et al.
Translocation of Connexin 43 to the Inner Mitochondrial Membrane of Cardiomyocytes Through the Heat Shock Protein 90-Dependent TOM Pathway and Its Importance for Cardioprotection
Circ. Res., July 7, 2006; 99(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J. Hausenloy and D. M. Yellon
Survival kinases in ischemic preconditioning and postconditioning
Cardiovasc Res, May 1, 2006; 70(2): 240 - 253.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, A. Rodriguez-Sinovas, M. Ruiz-Meana, J. Inserte, L. Agullo, and A. Cabestrero
The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion
Cardiovasc Res, May 1, 2006; 70(2): 274 - 285.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Inserte, D. Garcia-Dorado, V. Hernando, I. Barba, and J. Soler-Soler
Ischemic preconditioning prevents calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion
Cardiovasc Res, May 1, 2006; 70(2): 364 - 373.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado and H. M. Piper
Postconditioning: Reperfusion of "reperfusion injury" after hibernation
Cardiovasc Res, January 1, 2006; 69(1): 1 - 3.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. X. Jiang, J. Lertvorachon, S. T. Hou, Y. Konishi, J. Webster, G. Mealing, E. Brunette, J. Tauskela, and E. Preston
Chlortetracycline and Demeclocycline Inhibit Calpains and Protect Mouse Neurons against Glutamate Toxicity and Cerebral Ischemia
J. Biol. Chem., October 7, 2005; 280(40): 33811 - 33818.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Inserte, D. Garcia-Dorado, V. Hernando, and J. Soler-Soler
Calpain-Mediated Impairment of Na+/K+-ATPase Activity During Early Reperfusion Contributes to Cell Death After Myocardial Ischemia
Circ. Res., September 2, 2005; 97(5): 465 - 473.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.